OCT biomarkers of neurodegenerative diseases - reading the tea leaves or seeing the truth?
Clin Exp Optom
.
2023 Jan;106(1):102-103.
doi: 10.1080/08164622.2022.2081068.
Epub 2022 Jun 2.
Authors
Peter van Wijngaarden
1
2
,
Xavier Hadoux
1
,
Eirini Christinaki
3
,
Lies De Groef
4
5
,
Ingeborg Stalmans
3
6
7
Affiliations
1
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
2
Ophthalmology, Department of Surgery, University of Melbourne, Parkville, Australia.
3
Research Group Ophthalmology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
4
Development and Regeneration Research Group, Department of Biology, University of Leuven, Leuven, Belgium.
5
Leuven Brain Institute, University of Leuven, Leuven, Belgium.
6
Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.
7
Neural Circuit, and Development and Regeneration Research Group, Department of Biology, University of Leuven, Leuven, Belgium.
PMID:
35654477
DOI:
10.1080/08164622.2022.2081068
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Humans
Neurodegenerative Diseases* / diagnosis
Plant Leaves
Tea
Tomography, Optical Coherence
Substances
Tea
Biomarkers